UnitedHealth's $448B Empire Enters Turnaround Mode: Hemsley Returns, Margins Collapse, and AI Becomes the Recovery Bet

UnitedHealth Group posted $447.6B in 2025 revenue but saw its lowest profits since 2018 as Medicare Advantage costs spiraled. Returning CEO Stephen Hemsley is shrinking membership, divesting international operations, and betting on 1,000+ AI use cases to deliver nearly $1B in 2026 cost savings — while the stock trades 53% below its all-time high.

UNH · Health Care · February 26, 2026

S&P 500 Position

Largest company in the S&P 500 Health Care sector by revenue ($448B) but has been overtaken in market cap by several peers following a 50%+ drawdown from its November 2024 all-time high. Key competitors Elevance Health, Humana, Centene, and Molina Healthcare are all grappling with similar Medicare Advantage cost pressures, but none face UNH's combination of regulatory scrutiny — DOJ criminal fraud investigation, antitrust probes, and congressional subpoenas. Also a Dow Jones Industrial Average component, where its collapse from highest-weighted to 23rd-highest has dragged the index by roughly 4 percentage points over the past year.

Index Weight: ~0.40% | Rank: Approximately #40-50 in S&P 500 by market cap (59th globally)

Company Overview

UnitedHealth Group is executing the most aggressive operational reset in its history. After a catastrophic 2025 that saw Optum Health swing to a $278M operating loss (from $7.8B profit in 2024), a Change Healthcare cyberattack hangover, the assassination of UnitedHealthcare CEO Brian Thompson, and a DOJ criminal fraud investigation into Medicare Advantage billing, the company brought back Stephen Hemsley — who built the Optum franchise during his 2006-2017 tenure — to lead a turnaround. The strategy is counterintuitive for a company that historically grew through acquisition and membership expansion: UnitedHealth is deliberately shrinking. It expects to lose 2.3-2.8 million members in 2026 as it reprices plans, exits unprofitable Medicare Advantage geographies, and divests international operations including its UK and South American businesses. The dual-platform architecture — UnitedHealthcare as the insurance engine generating premiums and proprietary claims data, Optum as the technology and care delivery platform monetizing that data — remains the core structural advantage. But the flywheel broke down in 2025 when medical cost trends in Medicare Advantage hit ~7.5% against 5% pricing assumptions, and Optum Health's value-based care model absorbed the resulting losses. The 2026 playbook is margin recovery over growth: the company is guiding for $439B+ in revenue (a 2% decline) but >$24B in operating earnings with 40 basis points of margin expansion across both UnitedHealthcare and Optum. Hemsley has consolidated Optum Health's 18 EMR systems down to three, narrowed the affiliated provider network by 20%, and is leaning hard into AI-enabled cost reduction targeting nearly $1B in operating savings.

Products & Revenue

UnitedHealth Group operates as two complementary platforms — UnitedHealthcare (insurance) and Optum (health services/technology) — with significant intercompany revenue as medical spend increasingly stays within the vertically integrated ecosystem. UnitedHealthcare collects premiums and pays benefits; Optum delivers care (Optum Health), processes claims and provides analytics (Optum Insight), and manages pharmacy benefits (Optum Rx). Revenue eliminations have grown faster than top-line revenue over the past seven years, reflecting deeper vertical integration.

UnitedHealthcare (~56%): Health benefits serving 49.8M people across employer/individual, Medicare & Retirement, and Community & State (Medicaid). FY2025 revenue of $344.9B grew 16% YoY, driven by Medicare & Retirement (23% growth) and Community & State (17% growth).

Optum Rx (~25%): Pharmacy benefit management processing 1.66B adjusted scripts annually across retail network contracting, home delivery, specialty pharmacy, and clinical programs. FY2025 revenue of $154.7B grew 16% YoY, the only Optum segment generating meaningful profit growth.

Optum Health (~17%): Value-based care delivery through the largest employer of physicians in the U.S., including ambulatory, home health (Amedisys, LHC Group), and behavioral health. FY2025 revenue of $102.0B declined 3% and swung to a $278M operating loss from $7.8B profit in 2024.

Optum Insight (~3%): Health data analytics, revenue cycle management, consulting, and technology-enabled services sold to payers, providers, and life sciences companies. FY2025 revenue of $19.4B with a $32.9B contract backlog. Now includes Optum Financial Services after a recent reclassification.

Based on FY2025 full-year earnings release (January 27, 2026). Percentages are approximate and calculated on gross segment revenue before intercompany eliminations of ~$169B.

Leadership

Stephen J. Hemsley

CEO since 2025 (returned May 2025; previously CEO 2006-2017). Hemsley built Optum from scratch during his first CEO stint, transforming UnitedHealth from a pure insurer into a vertically integrated health services conglomerate. He started at Arthur Andersen as a managing partner, joined UNH in 1997 in financial roles, and became CEO in 2006. He returned in May 2025 after Andrew Witty stepped down, tasked with executing a turnaround amid the company's worst profitability since 2018 and multiple regulatory investigations.

Dr. Patrick Conway, CEO, Optum: A practicing pediatrician and former CMS chief medical officer, Conway also leads Optum Health directly. He is overseeing the restructuring of value-based care operations, narrowing the provider network by 20% and streamlining risk membership by 15%.

Sandeep Dadlani, CEO, Optum Insight (previously Chief Digital & Technology Officer): Moved from CDTO to Optum Insight CEO in September 2025. Former Mars Inc. CDO and Infosys global business head. Leads the AI-first product development strategy, overseeing 20,000+ engineers and the launch of products like Optum Real and AI Marketplace.

Wayne DeVeydt, Chief Financial Officer: Joined September 2025 from Bain Capital. Previously Anthem/Elevance CFO for nine years and CEO of Surgery Partners. Leading the financial discipline reset, targeting a return to 40% debt-to-capital ratio and margin expansion across all segments.

Tim Noel, CEO, UnitedHealthcare Medicare & Retirement: At the frontline of the Medicare Advantage crisis, managing the expected loss of 1.3-1.4M Medicare members in 2026 while repricing plans for ~10% medical cost trends. Publicly pushed back against CMS's proposed near-flat 2027 MA payment rates.

Craig Kurtzweil, Chief Data & Analytics Officer, UnitedHealthcare Commercial: Leads the data strategy powering consumer-facing AI tools like Smart Choice, Members Like You, and Claims Assistant. Has stated publicly that UnitedHealth is 'at our core, a data company.'

The AI Angle

1,000 AI use cases and counting — now it's existential

UnitedHealth has deployed over 1,000 AI applications in production across its operations, making it one of the most AI-saturated enterprises in healthcare. The numbers are staggering: AI chatbots handled 65 million customer calls in 2024, 18 million AI-enabled physician searches ran in Q1 2025 alone, and UNH's 20,000 engineers have accepted more than 60 million lines of AI-written code. The company's proprietary platform, United AI Studio, serves as the internal development environment, with a Responsible AI Review Board of clinicians, data scientists, ethicists, and legal experts reviewing hundreds of use cases monthly before production deployment. Key shipped products include Optum Real (a multi-payer AI claims solution that turns complex coverage rules into real-time payment predictions for providers), AI-powered pill validation in Optum Rx pharmacies performing 5 million checks per month, Claims Assistant (reducing out-of-network claim processing from 15 minutes to 3), and the Members Like You tool that uses demographic and claims data to predict care pathways and costs. The infrastructure strategy is primarily build-internal, leveraging UnitedHealth's unique data moat — longitudinal claims, clinical, and pharmacy data across 123 million Optum consumers and 49.8 million UnitedHealthcare members. However, the company partners with Microsoft, Google, and ServiceNow through its newly launched Optum AI Marketplace, a curated platform of healthcare-specific AI solutions with standardized APIs and sandbox environments designed to sell AI capabilities to external payers and providers. This 'competitor as customer' model gives Optum access to even broader datasets while generating high-margin revenue. Optum Insight, now led by former CDTO Sandeep Dadlani, has been positioned as the AI commercialization engine, with a $32.9B revenue backlog and new AI-powered claims processing tools that increase revenue cycle productivity by over 20%. The AI strategy carries material risk. The nH Predict debacle — a NaviHealth-developed AI tool that allegedly denied Medicare Advantage claims with a 90% error rate, triggering a 2023 class-action lawsuit — remains a reputational overhang. UnitedHealth has responded by stating it does not use AI to make adverse clinical determinations, but the DOJ's criminal fraud investigation into Medicare Advantage billing practices (potentially tied to AI-driven diagnostics) keeps the regulatory spotlight white-hot. Optum is also developing a next-generation Medicare risk scoring system using AI instead of traditional diagnosis codes, working with the Duke-Margolis Institute — a high-stakes bet that could reshape MA reimbursement if adopted. The financial case for AI is now existential, not optional. Management is projecting nearly $1 billion in AI-enabled operating cost reductions for 2026, a critical component of the margin recovery story. With medical cost trends running at ~10% in Medicare Advantage against near-flat CMS payment increases, technology-driven efficiency isn't a growth initiative — it's the primary lever for keeping the insurance business viable.

Financial Snapshot

Revenue (TTM): $447.6B — FY2025 | Net Income: $19.0B operating earnings (including $2.8B charge); $12.8B net income (implied from $13.19 TTM EPS × ~906M shares)

Margins: Operating ~4.2% (down from ~8.1% in 2024), net ~2.7% (MCR 88.9% vs 85.5% in 2024)

FY2025 was an inflection year in the wrong direction — revenue grew 12% to $448B but operating earnings fell dramatically as the medical care ratio spiked to 88.9%. Cash flows from operations remained robust at $19.7B (1.5x net income). The company has paused acquisitions and share buybacks to deleverage, targeting 40% debt-to-capital in 2026. The 2026 guide of >$439B revenue and >$17.75 adjusted EPS implies margin recovery to ~5.5% operating margins — still well below the 8%+ of 2023-2024.

1-Year Performance

$284.20 as of February 25, 2026. The stock has declined approximately 47% from its 52-week high and trades near its 52-week low.

UNH's stock cratered through a series of cascading crises: the Change Healthcare cyberattack (February 2024), the Brian Thompson assassination (December 2024), suspended guidance and CEO change (May 2025), and a DOJ criminal fraud investigation. Shares fell nearly 20% on January 27, 2026 alone after the Q4 report paired soft 2026 revenue guidance ($439B vs $454.6B consensus) with a near-flat CMS proposed MA payment rate for 2027. The stock now trades at a 623% premium to Morningstar's fair value estimate of $683, suggesting Wall Street sees deep value but near-term visibility is poor. Multiple analyst targets have been slashed — JPMorgan to $389, Barclays to $327.

Recent News

Fun Fact: UnitedHealth Group's Optum Insight division has quietly built a $32.9 billion revenue backlog — larger than the total annual revenue of companies like Snowflake or Palantir combined. The unit also recently consolidated Optum Health's employed physician groups from 18 different electronic medical record systems down to just three, one of the largest EMR standardization efforts ever undertaken in U.S. healthcare. The internal codename ecosystem traces back to Optum's origins: Hemsley created the Optum brand in 2011 by merging five separate subsidiaries (Ingenix, OptumHealth, Prescription Solutions, and others) under one umbrella — effectively building a $270B health services company inside an insurance company, a structural move no competitor has successfully replicated.